Matching trials
1,853 results
- Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) – Tuberculosis (TB) Co-infection: Complete Statistical AnalysisIndependent statistical analysis of Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country: Complete Statistical AnalysisIndependent statistical analysis of Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Operetta 2Independent statistical analysis of A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS): primary endpoint results, effect estimate with…
- Opt-INIndependent statistical analysis of Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01814072).
- OPTIMIZEComplete statistical analysis of the OPTIMIZE phase 3 trial of roflumilast dosing as add-on to standard COPD treatment in severe COPD, including trial design, discontinuation endpoints, logistic and Cox regression, adverse events,…
- OPTIMIZE-1Independent statistical analysis of A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery: primary endpoint…
- OPTIMIZE-2Independent statistical analysis of A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery: primary…
- Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OPTIMUMIndependent statistical analysis of Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02425644).
- Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN): Complete Statistical AnalysisIndependent statistical analysis of Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN): primary endpoint results, effect estimate with…
- Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD): Complete Statistical AnalysisIndependent statistical analysis of Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation: Complete Statistical AnalysisIndependent statistical analysis of Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women: Complete Statistical AnalysisIndependent statistical analysis of Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence: Complete Statistical AnalysisIndependent statistical analysis of Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01856712).
- ORBIT-3Independent statistical analysis of the randomized phase 3 ORBIT-3 trial evaluating ciprofloxacin dispersion for inhalation in non-CF bronchiectasis, including trial design, time-to-first-exacerbation methodology, planned analysis, and statistical interpretation.
- ORBIT-4An independent statistical analysis of the randomized phase 3 ORBIT-4 trial evaluating ciprofloxacin dispersion for inhalation versus placebo in non-CF bronchiectasis, including trial design, endpoint definition, planned time-to-event analysis, and statistical interpretation.
- ORCHARRDIndependent statistical analysis of Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- OReOIndependent statistical analysis of A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ORIENT-15Independent statistical analysis of ORIENT-15, the randomized phase 3 trial of sintilimab or placebo with chemotherapy in unresectable, locally advanced, recurrent or metastatic esophageal squamous cell carcinoma.
- ORIGAMAIndependent statistical analysis of Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ORIGINComplete statistical analysis of the ORIGIN phase 3 trial, including its factorial design, cardiovascular and diabetes endpoints, Cox and log-rank methods, odds ratios, confidence intervals, and statistical interpretation.
- ORIGINALComplete statistical analysis of the ORIGINAL phase 3 trial comparing tenecteplase with alteplase in Chinese patients with stroke, including trial design, non-inferiority methodology, efficacy, safety, and interpretation.
- ORIONIndependent statistical analysis of EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ORION-10Independent statistical analysis of Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ORION-4An independent statistical analysis of the randomized phase 3 ORION-4 trial evaluating inclisiran versus placebo for major adverse cardiovascular events in people with atherosclerotic cardiovascular disease.
- ORTHOVISC Shoulder Osteoarthritis Study: Complete Statistical AnalysisIndependent statistical analysis of ORTHOVISC Shoulder Osteoarthritis Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00436969).
- OSTROIndependent statistical analysis of Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery: primary endpoint results, effect estimate…
- Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PA 03-103Independent statistical analysis of Controlled Trial of Prenatal Vitamin D3 Supplementation to Prevent Vitamin D Deficiency in Mothers and Their Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PA.3An independent statistical analysis and educational interpretation of PA.3, a randomized phase 3 double-blind trial of Tarceva plus gemcitabine in patients with pancreatic cancer.
- PACIFICComplete statistical analysis of the PACIFIC phase 3 trial of MEDI4736 following concurrent chemoradiation in patients with stage III unresectable non-small cell lung cancer, including primary endpoints, time-to-event methods, secondary analyses, safety,…
- PACTIndependent statistical analysis and educational interpretation of PACT (NCT00272506), a phase 3 crossover trial evaluating inhaled corticosteroid and long-acting beta2-agonist therapy in pediatric asthma.
- Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3): Complete Statistical AnalysisIndependent statistical analysis of Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PALISADEAn independent statistical analysis of PALISADE, a randomized phase 3 trial evaluating factor XI inhibition in adults with peripheral artery disease, including its time-to-event endpoints, trial design, planned statistical methods, and interpretation.
- Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children: Complete Statistical AnalysisIndependent statistical analysis of Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PALLASComplete statistical analysis of the PALLAS phase 3 trial of dronedarone versus placebo in patients with permanent atrial fibrillation, including trial design, time-to-event endpoints, hazard ratios, confidence intervals, p-values, and statistical interpretation.
- PALOMA-2Independent statistical analysis of PALOMA-2 (NCT01740427), a randomized phase 3 trial of palbociclib plus letrozole versus placebo plus letrozole in postmenopausal women with ER+/HER2- advanced breast cancer.
- PALOMA-4Independent statistical analysis of PALOMA-4, a randomized phase 3 trial comparing palbociclib plus letrozole with placebo plus letrozole in Asian postmenopausal women with ER+/HER2- advanced breast cancer.
- Pamidronate to Treat Osteogenesis Imperfecta in Children: Complete Statistical AnalysisIndependent statistical analysis of Pamidronate to Treat Osteogenesis Imperfecta in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00005901).
- PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD): Complete Statistical AnalysisIndependent statistical analysis of PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Paracetamol With Caffeine to Treat Episodic Tension Type Headache: Complete Statistical AnalysisIndependent statistical analysis of Paracetamol With Caffeine to Treat Episodic Tension Type Headache: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755702).
- PARADIGM-2An independent statistical analysis of the randomized phase 3 PARADIGM-2 trial of nonacog beta pegol in patients with haemophilia B, including trial design, inhibitor endpoints, safety, planned statistical interpretation, and limitations.
- PARADIGM-HFAn independent statistical analysis of PARADIGM-HF, the phase 3 randomized trial comparing LCZ696 with enalapril in patients with heart failure with reduced ejection fraction.
- PARALLAXComplete statistical analysis of the PARALLAX phase 3 trial of sacubitril/valsartan versus individualized medical therapy in patients with heart failure with preserved ejection fraction, including endpoint definitions, mixed-effects and logistic regression methods,…
- Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris: primary endpoint results, effect estimate with confidence interval,…
- PATENT-1Independent statistical analysis of PATENT-1, a randomized phase 3 trial of oral riociguat in patients with pulmonary arterial hypertension, covering its 6-minute walking distance endpoint, ANCOVA, nonparametric and stratified analyses, secondary outcomes,…
- PATHIndependent statistical analysis of Perindopril Amlodipine for the Treatment of Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01556997).
- PEACE-1Independent statistical analysis of PEACE-1, a phase 3 trial evaluating abiraterone acetate, radiotherapy, androgen deprivation therapy, and docetaxel in metastatic hormone-naïve prostate cancer.
- PEARL-IVIndependent statistical analysis of A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…